Literature DB >> 24713657

RSV-encoded NS2 promotes epithelial cell shedding and distal airway obstruction.

Rachael M Liesman, Ursula J Buchholz, Cindy L Luongo, Lijuan Yang, Alan D Proia, John P DeVincenzo, Peter L Collins, Raymond J Pickles.   

Abstract

Respiratory syncytial virus (RSV) infection is the major cause of bronchiolitis in young children. The factors that contribute to the increased propensity of RSV-induced distal airway disease compared with other commonly encountered respiratory viruses remain unclear. Here, we identified the RSV-encoded nonstructural 2 (NS2) protein as a viral genetic determinant for initiating RSV-induced distal airway obstruction. Infection of human cartilaginous airway epithelium (HAE) and a hamster model of disease with recombinant respiratory viruses revealed that NS2 promotes shedding of infected epithelial cells, resulting in two consequences of virus infection. First, epithelial cell shedding accelerated the reduction of virus titers, presumably by clearing virus-infected cells from airway mucosa. Second, epithelial cells shedding into the narrow-diameter bronchiolar airway lumens resulted in rapid accumulation of detached, pleomorphic epithelial cells, leading to acute distal airway obstruction. Together, these data indicate that RSV infection of the airway epithelium, via the action of NS2, promotes epithelial cell shedding, which not only accelerates viral clearance but also contributes to acute obstruction of the distal airways. Our results identify RSV NS2 as a contributing factor for the enhanced propensity of RSV to cause severe airway disease in young children and suggest NS2 as a potential therapeutic target for reducing the severity of distal airway disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24713657      PMCID: PMC4001550          DOI: 10.1172/JCI72948

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  70 in total

1.  Infection of human airway epithelium by human and avian strains of influenza a virus.

Authors:  Catherine I Thompson; Wendy S Barclay; Maria C Zambon; Raymond J Pickles
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

2.  Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs.

Authors:  Amy C Sims; Ralph S Baric; Boyd Yount; Susan E Burkett; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

3.  The histopathology of fatal untreated human respiratory syncytial virus infection.

Authors:  Joyce E Johnson; Ricardo A Gonzales; Sandy J Olson; Peter F Wright; Barney S Graham
Journal:  Mod Pathol       Date:  2006-11-24       Impact factor: 7.842

4.  Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction.

Authors:  Murali Ramaswamy; Lei Shi; Steven M Varga; Sailen Barik; Mark A Behlke; Dwight C Look
Journal:  Virology       Date:  2005-10-10       Impact factor: 3.616

5.  Safety and immunogenicity of palivizumab (Synagis) administered for two seasons.

Authors:  Donald Null; Bernard Pollara; Penelope H Dennehy; Jean Steichen; Pablo J Sánchez; Laurence B Givner; David Carlin; Bernard Landry; Franklin H Top; Edward Connor
Journal:  Pediatr Infect Dis J       Date:  2005-11       Impact factor: 2.129

6.  The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

Authors:  Peter F Wright; Ruth A Karron; Shabir A Madhi; John J Treanor; James C King; Alice O'Shea; Mine R Ikizler; Yuwei Zhu; Peter L Collins; Clare Cutland; Valerie B Randolph; Anne M Deatly; Jill G Hackell; William C Gruber; Brian R Murphy
Journal:  J Infect Dis       Date:  2006-01-19       Impact factor: 5.226

7.  Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth.

Authors:  Vira Bitko; Olena Shulyayeva; Barsanjit Mazumder; Alla Musiyenko; Murali Ramaswamy; Dwight C Look; Sailen Barik
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.

Authors:  Timothy P Welliver; Jennifer L Reed; Robert C Welliver
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

9.  Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge.

Authors:  Alexander Bukreyev; Andrea Marzi; Friederike Feldmann; Liqun Zhang; Lijuan Yang; Jerrold M Ward; David W Dorward; Raymond J Pickles; Brian R Murphy; Heinz Feldmann; Peter L Collins
Journal:  Virology       Date:  2008-11-17       Impact factor: 3.616

10.  Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses.

Authors:  Timothy P Welliver; Roberto P Garofalo; Yashoda Hosakote; Karen H Hintz; Luis Avendano; Katherine Sanchez; Luis Velozo; Hasan Jafri; Susana Chavez-Bueno; Pearay L Ogra; LuAnn McKinney; Jennifer L Reed; Robert C Welliver
Journal:  J Infect Dis       Date:  2007-03-09       Impact factor: 5.226

View more
  51 in total

Review 1.  Ongoing developments in RSV prophylaxis: a clinician's analysis.

Authors:  Fariba Rezaee; Debra T Linfield; Terri J Harford; Giovanni Piedimonte
Journal:  Curr Opin Virol       Date:  2017-05-10       Impact factor: 7.090

2.  Central Role of the NF-κB Pathway in the Scgb1a1-Expressing Epithelium in Mediating Respiratory Syncytial Virus-Induced Airway Inflammation.

Authors:  Bing Tian; Jun Yang; Yingxin Zhao; Teodora Ivanciuc; Hong Sun; Maki Wakamiya; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

3.  Advanced Live Attenuated Vaccines for the Prevention of Respiratory Syncytial Virus Infections in Young Children.

Authors:  Octavio Ramilo; Rosa Rodriguez-Fernandez; Mark E Peeples; Asuncion Mejias
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

Review 4.  Importance of Virus Characteristics in Respiratory Syncytial Virus-Induced Disease.

Authors:  Homero San-Juan-Vergara; Mark E Peeples
Journal:  Immunol Allergy Clin North Am       Date:  2019-05-22       Impact factor: 3.479

Review 5.  Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.

Authors:  Cameron Griffiths; Steven J Drews; David J Marchant
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

6.  Ataxia telangiectasia mutated kinase mediates NF-κB serine 276 phosphorylation and interferon expression via the IRF7-RIG-I amplification loop in paramyxovirus infection.

Authors:  Ling Fang; Sanjeev Choudhary; Bing Tian; Istvan Boldogh; Chunying Yang; Teodora Ivanciuc; Yinghong Ma; Roberto P Garofalo; Allan R Brasier
Journal:  J Virol       Date:  2014-12-17       Impact factor: 5.103

Review 7.  Autoinflammatory disease in the lung.

Authors:  Thomas Scambler; Jonathan Holbrook; Sinisa Savic; Michael F McDermott; Daniel Peckham
Journal:  Immunology       Date:  2018-04-19       Impact factor: 7.397

8.  Primary differentiated respiratory epithelial cells respond to apical measles virus infection by shedding multinucleated giant cells.

Authors:  Wen-Hsuan W Lin; Annie J Tsay; Erin N Lalime; Andrew Pekosz; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

9.  Systematic Analysis of Cell-Type Differences in the Epithelial Secretome Reveals Insights into the Pathogenesis of Respiratory Syncytial Virus-Induced Lower Respiratory Tract Infections.

Authors:  Yingxin Zhao; Mohammad Jamaluddin; Yueqing Zhang; Hong Sun; Teodora Ivanciuc; Roberto P Garofalo; Allan R Brasier
Journal:  J Immunol       Date:  2017-03-03       Impact factor: 5.422

10.  Localization of the T-cell response to RSV infection is altered in infant mice.

Authors:  Katherine M Eichinger; Jessica L Kosanovich; Kerry M Empey
Journal:  Pediatr Pulmonol       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.